Suchergebnisse
Discover the power of regenerative agriculture with Biodel AG. Our innovative products, crafted through patented processes and exclusive blends, are designed to enhance soil vitality and boost plant health.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient...
Biodel Inc : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen Aktie Biodel Inc | | US09064M2044 | Nasdaq
25. Mai 2016 · Biodel Inc. and Albireo Limited, a privately held biopharmaceutical company, today announced that the companies, together with Albireo's stockholders, have entered into a definitive share...
BIODEL INC : Vorstellung des Unternehmens BIODEL INC, Aktionäre, Vorstände und Berufsbeschreibung, Finanzstärkerating, offizielle Mitteilungen, Kontaktdaten und Börsenkennzahlen | US09064M1053 | Nasdaq
Albireo Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders.
2. Nov. 2016 · Biodel will change its name to Albireo Pharma, Inc. and plans to change its ticker symbol on the NASDAQ Capital Market to ALBO. Ron Cooper will serve as the President and Chief Executive Officer of the combined company, with David Chiswell serving as the Chairman of the Board of Directors.
